Blue Jet Healthcare Ltd (BLUEJET) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Blue Jet Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
Intimation of Analyst and Investor call under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 scheduled to be held on 5th November, 2026
Intimation · 05 Nov 2026, 5:00 pm
Blue Jet Healthcare Schedules Q2 & H1 FY27 Earnings Call on 5th Nov'26 Blue Jet Healthcare Ltd. will host an earnings conference call on 5th Nov'26 at 5:00 PM IST to discuss its unaudited standalone financial results for the quarter and half-year ended 30th Sep'26. Key management participants include Managing Director Shiven Arora, COO V.K. Singh, CFO Ganesh Karuppannan, and Deputy CFO Sanjay Sinha. The CDMO company specializes in contrast media intermediates and high-intensity sweeteners, supplying global innovators including GE Healthcare, Guerbet, Bracco, Colgate Palmolive (India), and Unilever. Dial-in access is available via +91 22 6280 1107 / 7115 8008.
Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Intimation · 05 Nov 2026, 5:30 am
Blue Jet Healthcare Schedules Board Meeting to Approve Q2 FY27 Financial Results Blue Jet Healthcare Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited standalone financial results for the quarter and half-year ended 30th Sep'26, along with the Limited Review Report. Consequently, the trading window for dealing in company securities by designated persons and their immediate relatives remains closed and will reopen on 8th Nov'26, 48 hours following the declaration of the financial results.
BLUE JET HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 05 Nov 2026, 5:30 am
Scrutinizer''s Report and voting results for AGM
Annual General Meeting · 23 Sept 2026, 2:22 am
Outcome of 58th Annual General Meeting of the Company
Annual General Meeting · 21 Sept 2026, 6:50 pm
BRSR for FY 2025-26
Others (Uncategorized) · 18 Aug 2026, 7:49 pm
Notice of Annual General Meeting scheduled to be held on September 21, 2026
Annual General Meeting · 18 Aug 2026, 7:45 pm
Annual Report pertaining to FY 2025-26
Others (Uncategorized) · 18 Aug 2026, 7:41 pm
Transcript for Earnings call for the Financials Results for the quarter ended June 30, 2026
Transcript · 07 Aug 2026, 4:09 pm
Submission of Audio recording of earnings conference call pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Audio / Video · 04 Aug 2026, 2:22 am
Blue Jet Healthcare Submits Q1 FY27 Earnings Call Recording Blue Jet Healthcare has submitted the audio recording of its earnings conference call held on 3rd Aug'26. The call discussed the company's financial results for the quarter ended 30th Jun'26. The recording is now available on the company's website under the investor presentation section, as per SEBI regulations.
Investor Presentation for Financial Results for the quarter ended June 30, 2026
Investor Presentation · 03 Aug 2026, 9:05 pm
Blue Jet Q1FY27 YoY Revenue Declines on Lower PI Sales, Margins Compress Blue Jet Healthcare reported a 17% YoY revenue decline to ₹2,931mn for Q1FY27, primarily due to lower sales in the Pharma Intermediates (PI) category. EBITDA fell 19% YoY to ₹981mn, with margins contracting to 33% from 34% a year ago. PAT decreased 14% YoY to ₹783mn. Sequentially, performance improved, with revenue up 25% and EBITDA up 38% QoQ, driven by higher PI & API sales volume and operating leverage. The company also completed an ₹8,000mn fundraise through a QIP during the quarter.
As per attached file
Change in Auditor · 03 Aug 2026, 6:24 pm
Blue Jet Healthcare Q1'27 Results, Dividend, and Key Appointments Blue Jet Healthcare's Board approved unaudited results for the quarter ending 30 Jun'26, key management reappointments, and an FY26 dividend. Profit After Tax for Q1'27 was ₹782.64 million, a 21.6% YoY decrease but a 21.6% QoQ increase. The board also re-appointed Akshay B Arora as Executive Chairman and Shiven Akshay Arora as MD for five years from 13 Apr'27. A dividend of ₹1.2 per share (60%) for FY26 was recommended, with a record date of 14 Sep'26.
As per attached file
Dividend · 03 Aug 2026, 6:22 pm
Blue Jet Healthcare Q1'27 Results, Dividend, and Key Appointments Blue Jet Healthcare's board approved Q1 FY27 results and announced a Rs. 1.2/share dividend (60%) for FY26, with a record date of 14 Sep'26. Q1 PAT fell 14.1% YoY to Rs. 782.64 million, while revenue declined 17.4% YoY to Rs. 2,931.13 million. Sequentially, PAT grew 21.6% QoQ. Key approvals include the re-appointment of Akshay B Arora as Executive Chairman and Shiven Akshay Arora as Managing Director, both for five-year terms starting 13 Apr'27, and KKC & Associates as auditors for a second term.
As per attached file
Change in Management · 03 Aug 2026, 6:20 pm
Blue Jet Healthcare Board Approves Q1 Results and Key Appointments The board on Aug 03, '26, approved Q1 FY27 results, key management re-appointments, and a dividend. For the quarter ending Jun 30, '26, PAT was ₹782.64 mn on revenue of ₹2,931.13 mn. This compares to a PAT of ₹911.70 mn in Q1 FY26. The board re-appointed Akshay Arora as Executive Chairman and Shiven Arora as MD, both for five-year terms from Apr 13, '27. A dividend of ₹1.2/- per share for FY26 was confirmed, with a record date of Sep 14, '26. The AGM is scheduled for Sep 21, '26.
As per attached file
Financial Result · 03 Aug 2026, 6:18 pm
Blue Jet Healthcare Q1'27 Results, Management Re-appointments, and Dividend Record Date Blue Jet Healthcare's board approved Q1'27 unaudited results and key appointments on 03 Aug'26. Q1 profit was ₹782.64 million, a 21.6% QoQ increase but a 14.1% YoY decline. Revenue stood at ₹2,931.13 million, up 24.9% QoQ but down 17.4% YoY. The board also re-appointed Akshay Arora as Executive Chairman and Shiven Arora as MD, both for five-year terms from 13 Apr'27. A dividend of ₹1.2 per share (60%) for FY26 was confirmed, with a record date of 14 Sep'26.
Outcome of Board Meeting held on 3rd August, 2026
Outcome · 03 Aug 2026, 6:14 pm
Blue Jet Healthcare Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Million) ■ Revenue: 2,931 (-17.4% YoY | +24.9% QoQ) ■ EBITDA: 981 (-18.9% YoY | +37.6% QoQ) ■ EBITDA Margin (%): 33.5 (-65 bps YoY | +309 bps QoQ) ■ PAT: 783 (-14.2% YoY | +21.6% QoQ) ■ EPS (INR): 4.51 (-14.3% YoY | +21.6% QoQ)
Intimation of Analyst and Investor call scheduled to be held on August 3, 2026
Intimation · 03 Aug 2026, 5:30 pm
Blue Jet Healthcare Schedules Q1 FY27 Earnings Call for August 3, 2026 Blue Jet Healthcare (BSE: 544009, NSE: BLUEJET) has scheduled a conference call for analysts and investors on Mon, Aug 03, '26, at 5:30 PM IST. The management will discuss the unaudited standalone financial results for the quarter ended Jun 30, '26. Key management personnel, including the Managing Director, COO, and CFO, will be present.
Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve Unaudited Standalone Financial ....
Intimation · 03 Aug 2026, 5:30 am
Blue Jet Healthcare Board Meeting on Aug 03, '26 to Approve Q1 Results Blue Jet Healthcare's Board of Directors will meet on Aug 03, '26 to consider and approve the unaudited standalone financial results for the first quarter ending Jun 30, '26. The Trading Window for designated persons, which closed on Jun 25, '26, will remain shut until 48 hours after the results are declared. Consequently, the trading window is set to reopen on Aug 06, '26. This action is in compliance with SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
As per attached file
Press Release · 20 Jul 2026, 8:31 pm
Blue Jet Healthcare Awarded EcoVadis Silver Medal for ESG Performance Blue Jet Healthcare (NSE: BLUEJET) was awarded a Silver Medal by EcoVadis on Jul 20, '26, for its sustainability management practices. This places the company among the top 15% globally with a 90th percentile ranking. Blue Jet achieved a sustainability score of 77 out of 100, recognizing its performance in environment, labor & human rights, ethics, and sustainable procurement. The achievement reflects the company's progress in strengthening its environmental, social, and governance (ESG) practices across its operations, building on a previous EcoVadis Committed Badge.
Outcome of Investment & Finance Committee Meeting
Others (Uncategorized) · 10 Jul 2026, 4:18 am
Blue Jet Healthcare Raises ₹8,000 Million via Qualified Institutions Placement Blue Jet Healthcare's committee approved the allotment of 15,810,276 equity shares to qualified institutional buyers on 9th Jul'26. The issue price was set at ₹506.00 per share, a 4.83% discount to the floor price, raising an aggregate of ₹8,000 million. Major allottees include Shamyak Investment (34.38%) and ICICI Prudential Mutual Fund schemes (33.75%). Post-allotment, the company's paid-up equity share capital increased from ₹346.9M to ₹378.6M.
Outcome of Investment & Finance Committee meeting held on July 9, 2026
Others (Uncategorized) · 10 Jul 2026, 1:35 am
Blue Jet Healthcare Closes Qualified Institutions Placement (QIP) Blue Jet Healthcare's committee approved the closure and allocation of its QIP on 9th Jul'26. The company will issue 15,810,276 equity shares to qualified institutional buyers at ₹506.00 per share. This issue price represents a 4.83% discount to the floor price of ₹531.70. The placement document was also approved and adopted. This transaction facilitates capital raising from institutional investors.
Outcome of Investment and Finance Committee.
Others (Uncategorized) · 07 Jul 2026, 1:13 am
Blue Jet Healthcare Approves Qualified Institutional Placement (QIP) Blue Jet Healthcare's Investment and Finance Committee approved a Qualified Institutional Placement (QIP) on Jul 6, '26. The committee has set the floor price at ₹531.70 per equity share. The company may, at its discretion, offer a discount of up to 5% on the floor price. The issue opens on Jul 6, '26, with the final issue price to be determined in consultation with the book-running lead managers. This follows shareholder approval received via a special resolution on Jun 17, '26.
The earlier announcement made today was inadvertently submitted in wrong tab, hence reattaching herewith again. Request all to ignore the earlier captioned tab
Others (Uncategorized) · 06 Jul 2026, 9:26 pm
Blue Jet Healthcare FY26 Net Profit Declines 18.8% YoY on Lower Revenue Blue Jet Healthcare reported an 18.8% YoY decline in net profit to ₹2,478.16 million for FY26, down from ₹3,052.03 million in FY25. The decrease was driven by an 8.0% YoY fall in revenue from operations to ₹9,473.21 million. Earnings per share (EPS) for the year ended 31 Mar'26 stood at ₹14.29, compared to ₹17.59 in the previous year. The Board has proposed a final dividend of ₹1.20 per share for FY26, subject to shareholder approval at the upcoming Annual General Meeting.
Submission of Audited Standalone Financial Statement for the Financial Year ended March 31, 2026
Change in Auditor · 06 Jul 2026, 8:23 pm
Blue Jet Healthcare FY26 Standalone Financials Approved by Board Blue Jet Healthcare's Board of Directors approved the audited standalone financial statements for the year ended 31 Mar'26. Revenue from operations declined 8.0% YoY to ₹9,473.21 million, while profit after tax fell 18.8% YoY to ₹2,478.16 million. Consequently, basic EPS for FY26 stood at ₹14.29, down from ₹17.59 in the previous year. The Board has proposed a final dividend of ₹1.20 per share for FY26, subject to shareholder approval at the upcoming Annual General Meeting.